Filing Details
- Accession Number:
- 0001104659-25-050043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-16 16:30:26
- Reporting Period:
- 2025-05-14
- Filing Date:
- 2025-05-16
- Accepted Time:
- 2025-05-16 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681871 | Christina Ackermann | 3 More London Riverside London X0 SE1 2RE | Yes | No | No | No |
Transaction Summary
| Sold: | 40,000 shares | Avg. Price: $8.44 | Total Value: $337,600.00 |
| Number of Shares After Transactions: | 41,880 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-05-14 | 40,000 | $1.93 | 81,880 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-05-14 | 40,000 | $8.44 | 41,880 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Options (Right to Buy) | Disposition | 2025-05-14 | 40,000 | $0.00 | 40,000 | $1.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2034-04-28 | No | 4 | M | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on February 12, 2025.
- The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $8.3894 to $8.5688 per Ordinary Share, inclusive (or $67.115 to $68.55 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- Consists of 41,880 Ordinary Shares represented by 5,235 ADSs.
- The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer.
- The option is fully vested.
Billionaire Hedge Funds
